You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

 Google Custom Search
Hepatitis B News Articles
Entecavir Effective for Hepatitis B Patients with Liver Cancer
June 28, 2011
Causes of Death Among People with Hepatitis B and C
June 17, 2011
Prolonged Entecavir for Slow Responders
June 3, 2011
Mothers with Hepatitis B Can Safely Breastfeed
May 24, 2011
Is Hepatitis B Under-treated in U.S.?
May 20, 2011
Prenatal HBV Screening Helps Babies More than Moms
May 13, 2011
Tenofovir Improves Outcomes of HBV Acute-on-Chronic Liver Failure
May 10, 2011
Switch to Lamivudine Not as Effective as Staying on Entecavir
May 6, 2011
HBV Breakthrough Common in Patients Taking Oral Meds
May 3, 2011
Additional HBV Vaccine Dose Offers More Protection for People with HIV
April 24 2011
Kidney Toxicity Uncommon among People Taking Tenofovir for Hepatitis B
April 19 2011
Immune-Based Therapy GS-9620 Shows Promise for Hepatitis B
April 8, 2011
HBV Genotype Predicts HBeAg Seroconversion on Tenofovir
April 8, 2011
Entecavir Beats Adefovir for Hepatitis B Treatment
March 29, 2011
Hepatitis B Vaccination Dramatically Lowers Prevalence among U.S. Children
March 15, 2011
Entecavir Approved in Europe for Hepatitis B Patients with Decompensated Liver Disease
March 11, 2011
New Hepatitis B Surface Antigen Test Helps Assess Treatment Response
February 25, 2011
One-quarter of Patients Clear Hepatitis Delta with Pegylated Interferon
January 28, 2011
Hepatitis B Therapeutic Vaccine Appears Safe and Stimulates Immune Response
January 11, 2011
No Tenofovir Resistance after 3 Years among Chronic Hepatitis B Patients
January 7, 2011
Does Previous Hepatitis B Exposure Increase Liver Cancer Risk?
December 14, 2010
Alcohol and Diabetes Increase Risk of Liver Disease Progression in Hepatitis B Patients
December 3, 2010
AASLD 2010 - Talking Slides™ Update
November 16, 2010
Antiviral Therapy for Chronic Hepatitis B Patients with Decompensated Liver Cirrhosis
November 16, 2010
Bristol-Myers Squibb Enhances Co-pay Assistance Program for Entecavir (Baraclude) for Hepatitis B
November 16, 2010
Are IL28B Gene Variations Associated with Outcomes in People with Hepatitis B?
November 16, 2010
Telbivudine and Elective Cesarean Section Help Prevent Mother-to-child Hepatitis B Transmission
November 9, 2010
Add-on Hepsera Is More Effective and Durable Than a Switch to Baraclude as Rescue Therapy for Epivir-resistant Patients with Chronic Hepatitis B
November 9, 2010
Which Pegylated interferon alfa-2b Regimen Works Best for Chronic Hepatitis B?
November 5, 2010
Entecavir (Baraclude) Continues to Suppress HBV for 5 Years in Asian Patients
November 5, 2010
Tenofovir (Viread) Maintains HBV Suppression without Resistance for 4 Years
November 2, 2010
FDA Approves Entecavir (Baraclude) for Chronic Hepatitis B Patients with Decompensated Liver Disease
October 22, 2010
FDA Approves New Roche Hepatitis B Viral Load Test
October 22, 2010
AASLD and Trust for America's Health Call for Action on Hepatitis B and C
October 5, 2010
FDA Approves New Roche Hepatitis B Viral Load Test
October 1, 2010
Lymphoma Chemotherapy Can Cause Severe Hepatitis B Reactivation
September 28, 2010
Nearly 20% of New Hepatitis B Infections May Occur in Healthcare Settings
September 28, 2010
Androgen Receptor May Explain Why More Men with Hepatitis B Develop Liver Cancer
September 21, 2010
Pegylated Interferon Has Low Sustained Response Rate in HBeAg Negative Chronic Hepatitis B Patients
September 14, 2010
Long-term Entecavir Leads to Regression of Liver Fibrosis in Chronic Hepatitis B Patients
September 14, 2010
FDA Approves Abbott's Automated Hepatitis B Viral Load Test
September 3, 2010
Adding Adefovir Works Better than Entecavir Monotherapy for Lamivudine-resistant Hepatitis B Patients
August 27, 2010
Meta-analysis Finds Tenofovir and Entecavir Are Most Effective Antiviral Drugs for Chronic Hepatitis B
August 24, 2010
HBV DNA Decline at 24 Weeks Predicts Sustained Response to Pegylated Interferon for Chronic Hepatitis B
August 20, 2010
Hepatitis B Virus Infection Linked to Non-Hodgkin Lymphoma in South Korean Study
August 2, 2010
High HBV Viral Load and HBeAg Positive Status Increase Risk of Mother-to-child Hepatitis B Transmission Despite Vaccine
July 16, 2010
Is Routine Hepatitis B Screening Necessary Before Starting Cancer Chemotherapy?
July 12, 2010
U.S. Hepatitis B Prevalence in the HBV Vaccine Era
July 6, 2010
How Long Do Chronic Hepatitis B Patients Need to be Treated to Sustain HBeAg Seroconversion?
July 2, 2010
CDC Reports Increasing Incidence of Liver Cancer, Mostly Due to Chronic Hepatitis B and C
June 15, 2010
Sex Hormone Receptor May Explain Higher Risk of Hepatocellular Carcinoma in Men
June 11, 2010
HBeAg Decrease during Treatment Predicts Sustained Response to Pegylated Interferon for Chronic Hepatitis B
June 8, 2010
World Hepatitis Alliance Releases Major Report on Viral Hepatitis Policy at EASL Meeting
June 8, 2010
Safety Review Clears Continuation of Hepislav Hepatitis B Vaccine
June 4, 2010
Rifaximin Reduces Encephalopathy Recurrence, Improves Quality of Life in People with Liver Cirrhosis
June 4, 2010
Advocates Rally in San Francisco and Washington to Raise Awareness and Demand Funding for Hepatitis B and C
May 24, 2010
GlaxoSmithKline Halts Study of Eltrombopag (Promacta) in People with Liver Disease Due to Blood Clot Risk
May 18, 2010
Spontaneous Undetectable Hepatitis B Virus DNA Is Uncommon, especially without HBeAg Clearance
May 14, 2010
Measurable Neurocognitive Impairment Signals Hepatic Encephalopathy in People with Liver Cirrhosis
May 11, 2010
San Francisco Launches Hepatitis B Campaign to Raise Awareness in Asian Community
May 7, 2010
Longer Treatment with Pegylated Interferon Works Better for Hepatitis B Genotype D
May 7, 2010
Tenofovir (Viread) Effective for Treatment of Chronic Hepatitis B Patients with Suboptimal Response to Adefovir (Hepsera)
May 7, 2010
HBV DNA and HBsAg Levels Predict Likelihood of Sustained Response to Pegylated Interferon for Hepatitis B
April 27, 2010
MARS and Prometheus Artificial Liver Devices Offer Some Benefits for Patients with Liver Failure, but Did Not Improve Survival
April 27, 2010
Tenofovir (Viread) Demonstrates High Barrier to Resistance over 3 Years in Chronic Hepatitis B Patients
April 24, 2010
World Hepatitis Alliance Releases Major Report on Viral Hepatitis Policy at EASL Meeting
April 20, 2010
Tenofovir/emtricitabine (Truvada) Prevents Hepatitis B Recurrence after Liver Transplantation in Patients with Mild Kidney Impairment
April 20, 2010
EASL International Liver Congress Presents New Data on Hepatitis B and C Pathogenesis and Treatment
April 20, 2010
Many U.S. Babies Do Not Receive Recommended Therapy to Prevent Hepatitis B Infection
April 16, 2010
Traditional Chinese Medicine May Perform Better than Interferon or Lamivudine for Chronic Hepatitis B
April 6, 2010
Entecavir (Baraclude) Works Well in Patients With Adefovir-resistant Hepatitis B, but Lamivudine Resistance Compromises Efficacy
April 6, 2010
Entecavir (Baraclude) Works Well in Patients With Adefovir-resistant Hepatitis B, but Lamivudine Resistance Compromises Efficacy
April 2, 2010

 

 

 

 

 

 

 

 

 
 

Reports from Recent
Hepatitis-related
Research Conferences

Noimage

Noimage

Noimage

Baraclude / entecavir
Children / Infants
Cirrhosis
Clinical Trials
Epivir-HBV / lamivudine; 3TC
Experimental Treatments
FAQs About Hepatitis
FDA-approved Drugs (HBV)
Fibrosis
Genotypes
Guidelines
Hepatocellular Carcinoma
Hepsera / adefovir dipivoxil
Intron A / interferon alfa-2b
Liver Transplantation
Pegasys /
  
peginterferon alfa-2a
Steatosis
Viread / tenofovir
Tests for HBV
Tyzeka / telbivudine
Vaccines for HBV
Women